Neurogene (NGNE) EPS (Weighted Average and Diluted) (2018 - 2025)
Historic EPS (Weighted Average and Diluted) for Neurogene (NGNE) over the last 4 years, with Q3 2025 value amounting to -$0.99.
- Neurogene's EPS (Weighted Average and Diluted) rose 1680.67% to -$0.99 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.11, marking a year-over-year decrease of 107428.57%. This contributed to the annual value of -$4.31 for FY2024, which is 24708.32% down from last year.
- Per Neurogene's latest filing, its EPS (Weighted Average and Diluted) stood at -$0.99 for Q3 2025, which was up 1680.67% from -$1.05 recorded in Q2 2025.
- Over the past 5 years, Neurogene's EPS (Weighted Average and Diluted) peaked at $2.93 during Q4 2023, and registered a low of -$32.67 during Q3 2023.
- For the 3-year period, Neurogene's EPS (Weighted Average and Diluted) averaged around -$8.38, with its median value being -$1.09 (2024).
- Data for Neurogene's EPS (Weighted Average and Diluted) shows a peak YoY increase of 9646.39% (in 2024) and a maximum YoY decrease of 13818.81% (in 2024) over the last 5 years.
- Over the past 3 years, Neurogene's EPS (Weighted Average and Diluted) (Quarter) stood at $2.93 in 2023, then crashed by 138.19% to -$1.12 in 2024, then increased by 11.52% to -$0.99 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.99 for Q3 2025, versus -$1.05 for Q2 2025 and -$1.08 for Q1 2025.